(Q51342135)

3 April 2018

title

Successful use of fenfluramine as an add-on treatment for Dravet syndrome. (English)

1 reference

3 April 2018

author name string

Berten Ceulemans

1

1 reference

3 April 2018

Marc Boel

2

1 reference

3 April 2018

Katrien Leyssens

3

1 reference

3 April 2018

Carolin Van Rossem

4

1 reference

3 April 2018

Pieter Neels

5

1 reference

3 April 2018

Philippe G Jorens

6

1 reference

3 April 2018

Lieven Lagae

7

1 reference

3 April 2018

publication date

3 May 2012

1 reference

3 April 2018

published in

Epilepsia

1 reference

3 April 2018

volume

53

1 reference

3 April 2018

issue

7

1 reference

3 April 2018

page(s)

1131-1139

1 reference

3 April 2018

Syncopal attacks compulsively self-induced by Valsalva's maneuver associated with typical absence seizures. A case report

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2012.03495.X

A long-term follow-up study of Dravet syndrome up to adulthood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2012.03495.X

Dravet syndrome and deep brain stimulation: seizure control after 10 years of treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2012.03495.X

Nonpharmacologic treatments of Dravet syndrome: focus on the ketogenic diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2012.03495.X

Fenfluramine as a potential antiepileptic drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2012.03495.X

Overall management of patients with Dravet syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2012.03495.X

Severe myoclonic epilepsy in infancy: toward an optimal treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2012.03495.X

The pharmacologic treatment of Dravet syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2012.03495.X

Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2012.03495.X

De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2012.03495.X

Dopamine agonist treatment of self-induced pattern-sensitive epilepsy. A case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2012.03495.X

Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2012.03495.X

Fenfluramine disrupts the mitral valve interstitial cell response to serotonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2012.03495.X

Topiramate as add-on drug in severe myoclonic epilepsy in infancy: an Italian multicenter open trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2012.03495.X

Valvular regurgitation and surgery associated with fenfluramine use: an analysis of 5743 individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2012.03495.X

The core Dravet syndrome phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2012.03495.X

Severe myoclonic epilepsy in infancy (Dravet syndrome) 30 years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2012.03495.X

Compulsive respiratory stereotypies in children with autistic features: polygraphic recording and treatment with fenfluramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2012.03495.X

Dravet syndrome: the long-term outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2012.03495.X

The spectrum of SCN1A-related infantile epileptic encephalopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2012.03495.X

Epidemiology of Severe Myoclonic Epilepsy of Infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2012.03495.X

Addition of verapamil in the treatment of severe myoclonic epilepsy in infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2012.03495.X

Stiripentol open study in Japanese patients with Dravet syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2012.03495.X

Severe myoclonic epilepsy of infancy (Dravet syndrome): recognition and diagnosis in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2012.03495.X

The serotonergic and noradrenergic effects of antidepressant drugs are anticonvulsant, not proconvulsant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2012.03495.X

SCN1A duplications and deletions detected in Dravet syndrome: implications for molecular diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2012.03495.X

Protocadherin 19 mutations in girls with infantile-onset epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2012.03495.X

The genetics of Dravet syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2012.03495.X

Brain serotonin neurotoxicity and primary pulmonary hypertension from fenfluramine and dexfenfluramine. A systematic review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2012.03495.X

Coping with a child with Dravet syndrome: insights from families.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2012.03495.X

Severe myoclonic epilepsy in infants--a review based on the Tokyo Women's Medical University series of 84 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2012.03495.X

Progressive neurocognitive decline in two children with Dravet syndrome, de novo SCN1A truncations and different epileptic phenotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2012.03495.X

Microdeletions involving the SCN1A gene may be common in SCN1A-mutation-negative SMEI patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2012.03495.X

Clinical course of young patients with Dravet syndrome after vagal nerve stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2012.03495.X

10.1111/J.1528-1167.2012.03495.X

21 January 2018

Identifiers

DOI

1 reference

3 April 2018

PubMed ID

22554283

1 reference

3 April 2018